Motilal Oswal's research report on Procter Gamble Hygiene Health Care
P&G Hygiene and Healthcare (PGHH) delivered a weak performance on all parameters in 3QFY23. Ad-spends mounted sequentially to 12.1% of sales from 9.7% (albeit, declined 50bp YoY) during the quarter. The company reversed income tax provision of INR575m pertaining to earlier years based on favorable ruling by the Income Tax Appellate Tribunal in a similar case. Adjusted for this, PAT decreased 4.9% YoY to INR1,075m v/s our expectation of INR1,516m.
Outlook
While we remain positive on the long-term growth potentials of the sanitary napkin and healthcare businesses, the uncertain pace of sales and earnings recovery as well as expensive valuations of 53xFY24E EPS/ ~44xFY25E EPS lead us to maintain our Neutral rating. We value the stock at 50x Mar’25E EPS to arrive at our TP of INR15,050.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.